D-0146-2021 Class II Terminated
FDA drug recall D-0146-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 3, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 20, 2022). Affected quantity: 22,848 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 23, 2020
- Initiation Date
- Dec 3, 2020
- Termination Date
- Dec 20, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,848 cartons
Product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
M900412 December 2020 M904772 February 2021 M915745 October 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0146-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026